Use App
New
Connect your Agent
Trending
News
Earnings
All
DIA
0.53%
SPY
0.39%
QQQ
0.18%
Trending
SOL
1.41%
KHC
0.68%
ETH
2.16%
CPB
3.37%
BRK.B
0.41%
VKTX
2.62%
BITO
2.45%
LTC
5.27%
ZEC
6.59%
ALGO
2.29%
Feed
News
Sentiment
Earnings
Fundamentals
Info
home
Symbol
MDNAF
news
Exchange:
OTC
·
Updated 02:35 PM EDT
MDNAF News
News
all
press releases
Medicenna Therapeutics (MDNAF) Upgraded to Buy: Here's What You Should Know
Medicenna Therapeutics (MDNAF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
1
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile